Cybin (HELP) Gross Profit (2020 - 2021)

Cybin's (HELP) quarterly Gross Profit came in at $158019.7 in Q1 2021, up 100.1% on a QoQ basis from -$153.4 million in Q4 2020.

Cybin (HELP) Gross Profit (2020 - 2021) Analysis & Trends

Cybin (HELP) has 2 years of Gross Profit data on file, last reported at $158019.7 in Q1 2021.

Quarterly Gross Profit changed N/A year-over-year to $158019.7 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was -$9.0 million (changed N/A YoY) and the FY2021 annual result came in at $200.0, changed N/A from the prior year.
Gross Profit advanced to $158019.7 in Q1 2021, from -$153.4 million in the prior quarter.
In the past five years, Gross Profit ranged from a high of $144.2 million in Q2 2020 to a low of -$153.4 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Cybin	417.29 Mn	417.29 Mn	-

Download Data